Company Filing History:
Years Active: 2004
Title: Michael S O'Reilly: Innovator in Gene Therapy
Introduction
Michael S O'Reilly is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of angiogenesis-related diseases. His work focuses on the development of nucleic acids that encode for the endostatin protein, which has potential applications in combating cancer.
Latest Patents
O'Reilly holds a patent for "Nucleic acids encoding for endostatin protein." This patent includes ribonucleic and deoxyribonucleic acid sequences that are instrumental in gene therapy or recombinant expression. The endostatin protein is particularly useful in the treatment of angiogenesis-dependent cancers, highlighting the importance of his research in medical advancements.
Career Highlights
Michael S O'Reilly is affiliated with the Children's Medical Center Corporation, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in the advancement of gene therapy techniques.
Collaborations
O'Reilly has collaborated with M Judah Folkman, a prominent figure in the field of angiogenesis research. Their partnership has contributed to the understanding and development of therapies aimed at treating cancer through innovative approaches.
Conclusion
Michael S O'Reilly's work in gene therapy and his patent on endostatin protein encoding nucleic acids represent significant strides in medical research. His contributions continue to influence the treatment of angiogenesis-related diseases, showcasing the impact of innovation in healthcare.